ARKG Holdings of CDNA
CareDx
CareDx, Inc. is a biotechnology company specializing in precision medicine, focusing on the development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients. It generates revenue primarily through the sale of its proprietary testing services, including blood-based surveillance tests and genomic solutions that help improve transplant outcomes and patient care management.
Trades of CDNA in ARKG
The ten most recent trades of CareDx in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Jan 13, 2025 | Sell | $1,583,688 | 2.73% | 0.15% |
| Oct 30, 2024 | Sell | $745,558 | 1.34% | 0.06% |
| Oct 29, 2024 | Sell | $2,783,502 | 4.90% | 0.22% |
| Oct 28, 2024 | Sell | $153,593 | 0.26% | 0.01% |
| Oct 07, 2024 | Sell | $1,301,383 | 1.57% | 0.10% |
| Sep 06, 2024 | Sell | $254,680 | 0.36% | 0.02% |
| Sep 04, 2024 | Sell | $735,172 | 0.98% | 0.06% |
| Sep 03, 2024 | Sell | $694,337 | 0.86% | 0.05% |
| Aug 30, 2024 | Sell | $1,231,050 | 1.48% | 0.09% |
| Aug 23, 2024 | Sell | $2,564,400 | 2.92% | 0.18% |